Stryker Introduces its “SmartRobotics™ Stadium” to Indianapolis Indians Fans as Part of 10-City Tour of Minor League Ballparks

Today, Stryker continues its run with Minor League Baseball™ (MiLB™), stopping at Victory Field to bring the SmartRobotics™ Stadium booth to Indianapolis Indians fans. On Thursday, July 15 and Friday, July 16, Stryker will join fans at the ballpark to showcase the latest innovation in joint replacement technology, Mako SmartRobotics™.

Stryker will have a local orthopaedic surgeon on-site to speak with individuals about joint health and treatment options that may have been put off during the pandemic. Additionally, fans are encouraged to participate in engaging and entertaining activities in between innings at the booth.

“Whether you are looking for a fun night with the family or a new place to go with friends, Victory Field is a great place to catch the Indians play,” said Don Payerle, president of Stryker’s Joint Replacement division. “We invite the fans to visit our SmartRobotics™ Stadium booth to learn more about the importance of joint health so they can continue to jump to their feet and cheer for their team.”

Those in attendance will also learn more about Stryker during the games through videoboard commercials and promotions, including a seat upgrade for a lucky fan and a seventh-inning stretch promotion. In addition to the game day events, local orthopaedic surgeons will be back at Victory Field on Thursday, August 19, to host an educational seminar teaching fans about joint health and the latest treatment options, including Mako SmartRobotics™ robotic-arm assisted surgery and other nonsurgical options.

Lastly, as part of its “Own the Walk” charitable program, Stryker will donate $1 to K9s For Warriors – the nation’s largest provider of service dogs to American veterans living with military-related trauma – for every walk issued to a batter during the regular season. Stryker has been a committed partner of K9s For Warriors since 2015, having sponsored 31 service dogs to date — the largest number by any corporate partner.

It’s Time to Get Patients Back in the Game

At the start of the pandemic, many individuals and their physicians decided to delay necessary orthopaedic procedures, with some facilities having to stop them entirely until the pandemic was better controlled. However, putting off surgery could result in increased use of medications, a more difficult recovery and even more complicated surgeries, according to a recent Lancet study.[1] Now, it is time to ensure that healthcare professionals start to talk to patients again about revisiting their treatment options.

To register for the seminar on August 19 and learn more about joint health treatment options, please visit

SourceStryker

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”